Article
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease.
PloS one - 1 Jan 2016
Hampson Lynne, Maranga Innocent O, Masinde Millicent S, Oliver Anthony W, Batman Gavin, He Xiaotong, Desai Minaxi, Okemwa Parmenas M, Stringfellow Helen, Martin-Hirsch Pierre, Mwaniki Alex M, Gichangi Peter, Hampson Ian N
Abstract excerpt
BACKGROUND: Cervical cancer is the most common female malignancy in the developing nations and the third most common cancer in women globally. An effective, inexpensive and self-applied topical treatment would be an ideal solution for treatment of screen-detected, pre-invasive cervical disease in low resource settings. METHODS: Between 01/03/2013 and 01/08/2013, women attending Kenyatta National Hospital's Family...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.